OKYO
Pharma Limited

1,389
Mkt Cap
$82.71M
Volume
72,170.00
52W High
$3.35
52W Low
$1.03
PE Ratio
-13.24
OKYO Fundamentals
Price
$1.66
Prev Close
$1.61
Open
$1.56
50D MA
$1.81
Beta
0.73
Avg. Volume
108,265.44
EPS (Annual)
-$0.1192
P/B
-18.69
$48.59
Loading...
Loading...
News
all
press releases
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) was the target of a large drop in short interest during the month of March. As of March 13th, there was short interest totaling...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Down 12.4% in February
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) was the target of a significant drop in short interest in February. As of February 27th, there was short interest totaling 435,430...
MarketBeat·16d ago
News Placeholder
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Receives Consensus Rating of "Hold" from Analysts
Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are covering the firm, Marketbeat.com reports. One...
MarketBeat·16d ago
News Placeholder
OKYO Pharma (NASDAQ:OKYO) Raised to "Strong-Buy" at Piper Sandler
Piper Sandler raised OKYO Pharma to a "strong-buy" rating in a report on Friday...
MarketBeat·1mo ago
News Placeholder
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of "Hold" by Brokerages
Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have earned a consensus rating of "Hold" from the five ratings firms that are presently covering the firm, MarketBeat.com...
MarketBeat·1mo ago
News Placeholder
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Sees Significant Increase in Short Interest
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 30th, there was short interest...
MarketBeat·2mo ago
News Placeholder
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest...
MarketBeat·2mo ago
News Placeholder
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short...
MarketBeat·2mo ago
News Placeholder
OKYO Pharma (NASDAQ:OKYO) Trading Down 15.5% - What's Next?
OKYO Pharma (NASDAQ:OKYO) Shares Down 15.5% - Should You Sell...
MarketBeat·3mo ago
News Placeholder
OKYO Pharma CEO Gary Jacob Transitions To CDO; Appoints Robert Dempsey As CEO
(RTTNews) - OKYO Pharma Ltd. (OKYO), on Monday, said it has appointed Robert Dempsey as Chief Executive Officer, effective immediately...
Nasdaq News: Markets·3mo ago
<
1
2
...
>

Latest OKYO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.